Abstract:NAD+ plays critical roles in various biological functions. A number of studies have also indicated that NAD+ treatment can prevent the necrosis of primary neurons and astrocytes, which are induced by multiple insults such as oxidative stress. NAD+ administration has also been shown to decrease ischemic brain damage. However, there, there has been little information regarding the effects of NAD+ treatment on apoptotic changes, which are critical pathological changes in such neurological diseases as brain ischemia. In this study we determined the effects of NAD+ on multiple rotenone‐induced pathological changes by applying flow cytometry‐based Annexin V assay, TUNEL say, Hoechst staining and immunostaining of apoptosis‐inducing factor (AIF). We found that NAD+ treatment, but not nicotinamide, can markedly prevent all of these apoptotic changes, suggesting that NAD+ can prevent cell apoptosis by mechanisms that are independent of its degradation product nicotinamide. Our study using propidium staining assay and lactate dehydrogenase (LDH) assay also showed that NAD+ treatment can block rotenone‐induced cell necrosis. We further found that NAD+ treatment can prevent rotenone‐induced ATP depletion, which could in part underlie the protective effects of NAD+. In summary, our study has provided first evidence that NAD+ treatment can prevent multiple rotenone‐induced apoptotic changes, in addition to its reported preventive effects on cell necrosis. Because mitochondrial impairments belong to a key pathological change in multiple neurological diseases, our study has suggested that NAD+ may be used to prevent mitochondrial impairment‐induced cell death (Supported by a Key Research Grant of Shanghai Municipal Scientific Committee #08JC1415400 (to W. Y.)).

Nadh Can Induce Necrosis of C6 Glioma Cells and Neuro2a Cells

NADPH Treatment Induces Profound Necrosis of C6 Glioma Cells

Nad+ Induces C6 Glioma Cell Death by Generating Oxidative Stress and Increasing Intracellular Calcium Concentrations

NAD+ Treatment Induces Tumor Cell Necrosis by P2X7 Receptor‐Independent Pathways

NAD+ Treatment Decreases Tumor Cell Survival by Inducing Oxidative Stress.

Oxidative Stress and PARP Activation Mediate the NADH-induced Decrease in Glioma Cell Survival.

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

Nicotinamide Mononucleotide Can Decrease Rotenone‐Induced Necrosis and Apoptotic Changes of Neuro2a Cells

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

NAD+ Treatment Prevents Rotenone-Induced Apoptosis and Necrosis of Differentiated PC12 Cells

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

NAD+ Blocks H2O2‐induced HMGB1 Translocation of PC12 Cells and Decreases Survival of Microglia

Nad(+)/Nadh Metabolism And Nad(+)-Dependent Enzymes In Cell Death And Ischemic Brain Injury: Current Advances And Therapeutic Implications

NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation

Nad(+)-Carrying Mesoporous Silica Nanoparticles Can Prevent Oxidative Stress-Induced Energy Failures Of Both Rodent Astrocytes And Pc12 Cells

NAD+ administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage

D-galactose Induces Necroptotic Cell Death in Neuroblastoma Cell Lines.

Roles of NAD(+) / NADH and NADP(+) / NADPH in Cell Death.